Financial newspaper reports in the U.K. indicate that EG founders Mohsin and Zuber Issa hope to file paperwork for a debut in public markets next year and expect Wall Street will value the American ...
Senores Pharmaceuticals shares listed at 53% premium on NSE and 52% premium on BSE. Following the bumper debut, the stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback